v3.26.1
Condensed Statements of Changes in Stockholders’ Equity (Unaudited) - USD ($)
Preferred Stock
Common Stock
Treasury Stock
Additionalb Paid-In Capital
Accumulated Other Comprehensive Income
Accumulated Deficit
Total
Balance at Dec. 31, 2024 $ 170 $ (172) $ 75,173,627 $ (71,862,617) $ 3,311,008
Balance (in Shares) at Dec. 31, 2024 1,696,904          
Balance (in Shares) at Dec. 31, 2024     1,550        
Stock-based compensation expense 1,158 1,158
Vesting of restricted stock 14,743 14,743
Vesting of restricted stock (in Shares) 152          
Issuance of common stock through exercise of prefunded warrants $ 80 (80)  
Issuance of common stock through exercise of prefunded warrants (in Shares) 799,631          
Net loss (1,658,396) (1,658,396)
Balance at Mar. 31, 2025 $ 250 $ (172) 75,189,448 (73,521,013) 1,668,513
Balance (in Shares) at Mar. 31, 2025 2,496,687          
Balance (in Shares) at Mar. 31, 2025     1,550        
Balance at Dec. 31, 2025 $ 1 $ 848 $ (172) 85,437,703 (82,350,149) $ 3,088,231
Balance (in Shares) at Dec. 31, 2025 6,875 211,965         211,965
Balance (in Shares) at Dec. 31, 2025     39       1,550
Stock-based compensation expense 153 $ 153
Vesting of restricted stock 875 875
Vesting of restricted stock (in Shares)            
Issuance of common stock through exercise of prefunded warrants $ 129 (129)
Issuance of common stock through exercise of prefunded warrants (in Shares) 32,311          
Issuance of common stock through conversion of Series C convertible preferred stock $ (1) $ 1,990 (1,989)  
Issuance of common stock through conversion of Series C convertible preferred stock (in Shares) (3,830) 497,280          
Net loss (2,275,221) (2,275,221)
Balance at Mar. 31, 2026 $ 2,967 $ (172) $ 85,436,613 $ (84,625,370) $ 814,038
Balance (in Shares) at Mar. 31, 2026 3,045 741,556         741,556
Balance (in Shares) at Mar. 31, 2026     39       1,550